Sign in
4

Changes in Ownership

Prelude Therapeutics Inc Filed Acc 0001562180-25-000955

Options or other derivatives

  • CEO acquired 496,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Vaddi Krishna CEO 2025-02-04 Grant or award · Employee Stock Option (right to buy) +496,000 496,000 D
Loading xslF345X05/primarydocument.xml…